WELCOME TO THE MANUFACTURING REPORT
The Content Advisory
Q&A with Robert Rose, Founder and Chief Strategy Officer at The Content Advisory
The Content Advisory | June 19, 2019
Agencies are banking on content marketing. That’s the key finding in the newly released Content Marketing Institute 2019 Agency Survey. This inaugural research looks at how full-scope agencies, as well as specialized agencies, are doing content marketing for clients, how well it’s working, and some new opportunities. This survey expands on CMI’s previous agency research, which had only focused on how agencies use content for their own marketing. Nearly half of respondents from ...
The Content Advisory | July 24, 2019
The Content Marketing Institute (CMI) just announced the 85 category winners as well as the finalists for the top seven prizes in the prestigious 2019 Content Marketing Awards. The Content Marketing Awards, produced by the Content Marketing Institute, is the largest and longest-running international content marketing awards program in the world. This year’s panel of all-star judges reviewed nearly 1,100 entries to choose the best of the best in content marketing excellence, recognizing all...
Keppel Offshore & Marine, Lloyd's Register | January 14, 2020
Keppel Offshore & Marine has received Lloyd’s Register LR Certification to additively manufacture offshore grade steel with a 3D printing technology from Singapore Institute of Manufacturing Technology SIMTech. The certification was granted after assessing Keppel O&M’s production processes, from design to post-processing and testing. Partnering with Nanyang Technological University, Singapore NTU Singapore and SIMTech’s Agency for Science, Technology and Research A*STAR...
Outsourcing-Pharma.com | January 13, 2020
BMS and Catalent disclosed the deal for the site in June, at which time they hoped to work through the regulatory approvals and union consultations needed to close the transaction by the end of the year. One week into 2020, Bristol-Myers revealed it had closed the deal. The deal covers a 19,300-square-meter manufacturing facility in Anagni, a town in central Italy, that lists cardiovascular, neuroleptics, anticancer, metabolic and anti-inflammatory medicines among the drugs it makes and packages...
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE